{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:51:53Z","timestamp":1794585113398,"version":"4.9.1"},"reference-count":60,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cCritical and biomedical technologies for new shock medicine\u201d, Laboratory of Myocardial Infarction-Associated Shock","award":["075-00712-24-04"],"award-info":[{"award-number":["075-00712-24-04"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Myocardial infarction complicated by cardiogenic shock (MI-CS) remains a critical condition with high mortality rates, despite advances in treatment. Systemic inflammation plays a significant role in MI-CS progression; however, its dynamics across different stages of the Society for Cardiovascular Angiography and Interventions (SCAI) classification remain poorly understood. This study aimed to evaluate indices of systemic inflammation\u2014neutrophil\u2013lymphocyte ratio (NLR), platelet\u2013lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI)\u2014in MI-CS patients, correlating them with SCAI stages and survival outcomes. Methods: A single-center retrospective study included 132 patients with MI-CS, categorized into SCAI stages A\u2013E. All patients were assessed for demographic, clinical, and laboratory data, procedural and treatment characteristics, MI timing, and outcomes. Complete blood count test data were used to calculate inflammatory indices and evaluate types of immune reactions. Results: PLR, SII, and AISI peaked at SCAI stage C and declined significantly at stage E, suggesting suppressed inflammation in advanced shock. SIRI emerged as a key prognostic marker for stage C patients, with elevated levels associated with larger infarct size, higher heart rate, and predominant innate immune activation. Patients with SIRI \u2265 3.34 had significantly lower two-year survival (log-rank test, p = 0.006). Conclusions: Inflammation indices, particularly SIRI, provide valuable prognostic insights in MI-CS, reflecting disease severity and heterogeneity of immune response. The decline in inflammatory indices at SCAI stage E may indicate immune suppression in extreme MI-CS, underscoring the need for personalized therapeutic strategies.<\/jats:p>","DOI":"10.3390\/jcm14124283","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T09:51:22Z","timestamp":1750067482000},"page":"4283","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inflammatory Indices in Patients with Myocardial Infarction Complicated by Cardiogenic Shock, and Their Interconnections with SCAI Stages and Patients\u2019 Survival: A Retrospective Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-0008","authenticated-orcid":false,"given":"Irina","family":"Kologrivova","sequence":"first","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111A Kievskaya, Tomsk 634012, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1444-1037","authenticated-orcid":false,"given":"Maria","family":"Kercheva","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111A Kievskaya, Tomsk 634012, Russia"},{"name":"Cardiology Division, Siberian State Medical University, 2 Moscovsky Trakt, Tomsk 634055, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Panteleev","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111A Kievskaya, Tomsk 634012, Russia"},{"name":"Cardiology Division, Siberian State Medical University, 2 Moscovsky Trakt, Tomsk 634055, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Dmitriukov","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111A Kievskaya, Tomsk 634012, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Zenkov","sequence":"additional","affiliation":[{"name":"Cardiology Division, Siberian State Medical University, 2 Moscovsky Trakt, Tomsk 634055, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Suslova","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111A Kievskaya, Tomsk 634012, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-7329","authenticated-orcid":false,"given":"Vyacheslav","family":"Ryabov","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111A Kievskaya, Tomsk 634012, Russia"},{"name":"Cardiology Division, Siberian State Medical University, 2 Moscovsky Trakt, Tomsk 634055, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic Shock After Acute Myocardial Infarction: A Review","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/SHK.0000000000001377","article-title":"Cardiogenic Shock Following Acute Myocardial Infarction: What\u2019s New?","volume":"53","author":"Pepe","year":"2020","journal-title":"Shock"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Dil, S., Kercheva, M., Panteleev, O., Demianov, S., Kanev, A., Belich, N., Kornienko, B., and Ryabov, V. (2025). Myocardial Infarction-Associated Shock: A Comprehensive Analysis of Phenotypes, SCAI Classification, and Outcome Assessment. Medicina, 61.","DOI":"10.3390\/medicina61010103"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccc.2023.05.001","article-title":"Cardiogenic Shock: Pathogenesis, Classification, and Management","volume":"40","author":"Sarma","year":"2024","journal-title":"Crit. Care Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: An update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.29001\/2073-8552-2021-36-4-45-51","article-title":"Cardiogenic shock: What\u2019s new?","volume":"36","author":"Panteleev","year":"2021","journal-title":"Sib. J. Clin. Exp. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kercheva, M., Ryabov, V., Gombozhapova, A., Rebenkova, M., and Kzhyshkowska, J. (2022). Macrophages of the \"Heart-Kidney\" Axis: Their Dynamics and Correlations with Clinical Data and Outcomes in Patients with Myocardial Infarction. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020127"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00392-023-02336-8","article-title":"Association of systemic inflammation with shock severity, 30-day mortality, and therapy response in patients with cardiogenic shock","volume":"113","author":"Dettling","year":"2024","journal-title":"Clin. Res. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/eurheartj\/ehab110","article-title":"The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction","volume":"42","author":"Ceglarek","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1093\/eurheartj\/ehz294","article-title":"Protein-based cardiogenic shock patient classifier","volume":"40","author":"Rueda","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Galusko, V., Wenzl, F.A., Vandenbriele, C., Panoulas, V., L\u00fcscher, T.F., and Gorog, D.A. (2025). Current and novel biomarkers in cardiogenic shock. Eur. J. Heart Fail.","DOI":"10.1002\/ejhf.3531"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2160348","DOI":"10.1080\/0886022X.2022.2160348","article-title":"The systemic inflammation indexes predict all-cause mortality in peritoneal dialysis patients","volume":"45","author":"Yang","year":"2023","journal-title":"Ren. Fail."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ma, Y., and Geng, X. (2024). Prognostic value of the systemic inflammation response index on 3-year outcomes of elderly patients with acute coronary syndrome after stent implantation. Adv. Clin. Exp. Med.","DOI":"10.17219\/acem\/190739"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wei\u00df, E., Ramos, G.C., and Delgobo, M. (2022). Myocardial-Treg Crosstalk: How to Tame a Wolf. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.914033"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcrc.2021.12.005","article-title":"Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity","volume":"68","author":"Jentzer","year":"2022","journal-title":"J. Crit. Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3758068","DOI":"10.1155\/2018\/3758068","article-title":"Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?","volume":"2018","author":"Djordjevic","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wei, X., Zhang, Z., Wei, J., and Luo, C. (2023). Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1248655"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhou, H., Li, X., Wang, W., Zha, Y., Gao, G., Li, S., Liu, B., and Guo, R. (2024). Immune-inflammatory biomarkers for the occurrence of MACE in patients with myocardial infarction with non-obstructive coronary arteries. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1367919"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.2147\/IJGM.S480204","article-title":"A Comprehensive Analysis Exploring the Vital Role of the Systemic Immune-Inflammatory Index Upon Admission in Severe Hemorrhagic Fever with Renal Syndrome","volume":"17","author":"Yao","year":"2024","journal-title":"Int. J. Gen. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e33967","DOI":"10.1097\/MD.0000000000033967","article-title":"The association and prognostic value of systemic inflammatory response index with short and long-term mortality in patients with sepsis","volume":"102","author":"Ru","year":"2023","journal-title":"Medicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/j.jemermed.2024.05.005","article-title":"The Combination of Systemic Immune-Inflammation Index and Serum Procalcitonin has High Auxiliary Predictive Value for Short-Term Adverse Prognosis in Septic Shock Patients","volume":"67","author":"Li","year":"2024","journal-title":"J. Emerg. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1573403X15666181212125024","article-title":"Shock\u2014Classification and Pathophysiological Principles of Therapeutics","volume":"15","author":"Kislitsina","year":"2019","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Marchi, F., Pylypiv, N., Parlanti, A., Storti, S., Gaggini, M., Paradossi, U., Berti, S., and Vassalle, C. (2024). Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction. J. Clin. Med., 13.","DOI":"10.3390\/jcm13051256"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Borisov, R.N., Zdzitovetskii, D.E., Kasparov, E.V., Savchenko, A.A., Borisov, S.A., Berdnikov, D.S., Govorukha, E.S., and Boldyrev, P.N. (2019). Types of immune system reactions and their characteristic in patients with generalized purulent peritonitis. Sib. Med. Rev., 80\u201387.","DOI":"10.20333\/2500136-2019-5-80-87"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e006956","DOI":"10.1161\/CIRCOUTCOMES.120.006956","article-title":"Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients","volume":"13","author":"Jentzer","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cuinet, J., Garbagnati, A., Rusca, M., Yerly, P., Schneider, A.G., Kirsch, M., and Liaudet, L. (2020). Cardiogenic shock elicits acute inflammation, delayed eosinophilia, and depletion of immune cells in most severe cases. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64702-0"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/ehjacc\/zuad018","article-title":"Inflammatory response by 48 h after admission and mortality in patients with acute myocardial infarction complicated by cardiogenic shock","volume":"12","author":"Kunkel","year":"2023","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13063-021-05947-6","article-title":"Low-dose corticosteroid therapy for cardiogenic shock in adults (COCCA): Study protocol for a randomized controlled trial","volume":"23","author":"Dessap","year":"2022","journal-title":"Trials"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/SHK.0000000000000756","article-title":"GREAT Network. Infectious Complications and Immune\/Inflammatory Response in Cardiogenic Shock Patients: A Prospective Observational Study","volume":"47","author":"Parenica","year":"2017","journal-title":"Shock"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"103013","DOI":"10.1016\/j.eclinm.2024.103013","article-title":"Identifying biomarker-driven subphenotypes of cardiogenic shock: Analysis of prospective cohorts and randomized controlled trials","volume":"79","author":"Soussi","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nunez, J.I., Uehara, M., Patel, S.R., Forest, S.J., Rochlani, Y., Madan, S., Sims, D.B., Mellas, N., Ashley, J.E., and Rahmanian, M. (2025). Changes in Neutrophil-to-Lymphocyte Ratio During Venoarterial Extracorporeal Membrane Oxygenation. ASAIO J.","DOI":"10.1097\/MAT.0000000000002376"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kologrivova, I., Kercheva, M., Panteleev, O., and Ryabov, V. (2024). The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Narrative Review. Biomedicines, 12.","DOI":"10.3390\/biomedicines12092073"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00134-024-07618-x","article-title":"Management of cardiogenic shock: State-of-the-art","volume":"50","author":"Jung","year":"2024","journal-title":"Intensive Care Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3349\/ymj.2020.61.10.851","article-title":"Clinical Implications of Thrombocytopenia at Cardiogenic Shock Presentation: Data from a Multicenter Registry","volume":"61","author":"Lee","year":"2020","journal-title":"Yonsei Med. J."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wang, L., Shao, J., Shao, C., Wang, H., Jia, M., and Hou, X. (2021). The Relative Early Decrease in Platelet Count Is Associated with Mortality in Post-cardiotomy Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation. Front. Med., 8.","DOI":"10.3389\/fmed.2021.733946"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00392-013-0656-0","article-title":"The Th17\/Treg imbalance in patients with cardiogenic shock","volume":"103","author":"Link","year":"2014","journal-title":"Clin. Res. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood-2012-04-426734","article-title":"Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature","volume":"121","author":"Kleinschnitz","year":"2013","journal-title":"Blood"},{"key":"ref_41","first-page":"56","article-title":"Sepsis-induced immunosuppression: Mechanisms, diagnosis and current treatment options","volume":"9","author":"Liu","year":"2022","journal-title":"Mil. Med. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e41094","DOI":"10.1097\/MD.0000000000041094","article-title":"The progression of non-culprit coronary lesion is related to higher SII, SIRI, and PIV in patients with ACS","volume":"103","author":"Yilu","year":"2024","journal-title":"Medicine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.31083\/j.rcm2405153","article-title":"The Impact of Systemic Inflammation Response Index on the Prognosis of Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention","volume":"24","author":"Qu","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/07853890.2022.2083671","article-title":"Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"54","author":"Han","year":"2022","journal-title":"Ann. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10760296221146183","DOI":"10.1177\/10760296221146183","article-title":"The Prognostic Value of Hematologic Inflammatory Markers in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention","volume":"28","author":"Fan","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e39029","DOI":"10.1016\/j.heliyon.2024.e39029","article-title":"The predictive role of Systemic Inflammation Response Index (SIRI), Neutrophil-Lymphocyte Ratio (NLR), and Platelet-Lymphocyte Ratio (PLR) in the prognosis of acute coronary syndrome in the prognosis of acute coronary syndrome in a tertiary care hospital","volume":"10","author":"Rajakumar","year":"2024","journal-title":"Heliyon"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ehf2.12266","article-title":"Acute heart failure following myocardial infarction: Complement activation correlates with the severity of heart failure in patients developing cardiogenic shock","volume":"5","author":"Orrem","year":"2018","journal-title":"ESC Heart Fail."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2013.10.013","article-title":"Toll-like receptors 2 and 4 modulate autonomic control of heart rate and energy metabolism","volume":"36","author":"Okun","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Al-Rashed, F., Sindhu, S., Al Madhoun, A., Ahmad, Z., AlMekhled, D., Azim, R., Al-Kandari, S., Wahid, M.A., Al-Mulla, F., and Ahmad, R. (2021). Elevated resting heart rate as a predictor of inflammation and cardiovascular risk in healthy obese individuals. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-93449-5"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Frasch, M.G. (2022). Heart Rate as a Non-Invasive Biomarker of Inflammation: Implications for Digital Health. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.930445"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"zuad036.131","DOI":"10.1093\/ehjacc\/zuad036.131","article-title":"Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development -- rationale and design of the DOBERMANN trial","volume":"12","author":"Kunkel","year":"2023","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejcts.2007.04.038","article-title":"Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: A randomised double-blind study","volume":"32","author":"Fattouch","year":"2007","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.1601","article-title":"Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: Dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics","volume":"22","author":"Deniau","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Torzewski, J., Mattecka, S., Ries, W., Garlichs, C.D., Heigl, F., Fiedler, J., and Sheriff, A. (2023). Case report: C-reactive protein apheresis in cardiogenic shock: Case series from the C-reactive protein apheresis in acute myocardial infarction-registry. Front. Drug Discov., 3.","DOI":"10.3389\/fddsv.2023.1286710"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","article-title":"Immune dysregulation in sepsis: Experiences, lessons and perspectives","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Wu, Y., Wang, L., Li, Y., Cao, Y., Wang, M., Deng, Z., and Kang, H. (2024). Immunotherapy in the context of sepsis-induced immunological dysregulation. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1391395"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in acute myocardial infarction: The good, the bad and the ugly","volume":"45","author":"Matter","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/eurjpc\/zwaa013","article-title":"The overlooked tsunami of systemic inflammation in post-myocardial infarction cardiogenic shock","volume":"29","author":"Montero","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/s13063-024-08573-0","article-title":"Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): Study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial","volume":"25","author":"Kunkel","year":"2024","journal-title":"Trials"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Santas, E., Villar, S., Palau, P., Ll\u00e0cer, P., de la Espriella, R., Mi\u00f1ana, G., Lorenzo, M., N\u00fa\u00f1ez-Mar\u00edn, G., G\u00f3rriz, J.L., and Carratal\u00e1, A. (2024). High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-72137-0"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4283\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:52:58Z","timestamp":1760032378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14124283"],"URL":"https:\/\/doi.org\/10.3390\/jcm14124283","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]}}}